Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 130 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Egilman AC, Zhang AD, Wallach JD, Ross JS. Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors . Ann Intern Med 2019:1. [Ref.ID 103162]
2.Enlace a cita original Cita con resumen
Moore N, Duret S, Grolleau A, Lassalle R, Barbet V, Duong M, Thurin N, Droz-Perroteau C, Gulmez SE. Previous drug exposure in patients hospitalised for acute liver injury: a case-population study in the French National Healthcare Data System. Drug Saf 2019;42:abril. [Ref.ID 103083]
3. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
4. Cita con resumen
Anónimo. Comparative effectiveness of proton pump inhibitors. Therapeutics Initiative Evidence Based Drug Therapy 2016;99:1-2. [Ref.ID 100573]
5.Enlace a cita original Cita con resumen
Begley J, Smith T, Burnett K, Strike P, Azim A, Spake C, Richardson T. Proton pump inhibitor hypomagnasemia - a cause for concern?. Br J Clin Pharmacol 2016;81:753-8. [Ref.ID 100179]
6. Cita con resumen
Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 2016:14 de abril. [Ref.ID 100161]
7. Cita con resumen
Anónimo. Dr. Reddy’s changes color of generic drug after court ruling. DIA Daily 2015:31 de diciembre. [Ref.ID 99743]
8. Cita con resumen
Anónimo. Consolidations de fracture retardées par des médicaments. Prescrire 2015;35:507-12. [Ref.ID 99440]
9. Cita con resumen
Anónimo. Which PPI?. Med Lett Drugs Ther 2015;57:8-9. [Ref.ID 99216]
10. Cita con resumen
Shah NH, LePendu P, Bauer-Mehren A, Ghebremariam YT, Iyer SV, Marcus J, Nead KT, Cooke JP, Leeper NJ. Proton pump inhibitor usage and the risk of myocardial infarction in the general population. PLoS One 2015:10 de junio. [Ref.ID 99197]
11. Cita con resumen
Sung JJY, Suen B-Y, Wu JCY, Lau JYW, Ching JYL, Lee VWL, Chiu PWY, Tsoi KKF, Chan FKL. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy. Am J Gastroenterol 2014;109:1005-10. [Ref.ID 97601]
12.Tiene citas relacionadas Cita con resumen
Maggio M, Corsonello A, Ceda GP, Cattabiani C, Lauretani F, Buttò V, Ferrucci L, Bandinelli S, Abbatecola AM, Spazzafumo L, Lattanzio F. Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. JAMA Intern Med 2013;173:518-23. [Ref.ID 95257]
13.Enlace a cita original
Dworzynski K, Pollit V, Kelsey A, Higgins B, Palmer K, on behalf of the Guideline Development Group. Management of acute upper gastrointestinal bleeding: summary of NICE guidance. BMJ 2012;344:45-7. [Ref.ID 93219]
14.Enlace a cita original Cita con resumen
Anónimo. Riesgo de hipomagnesemia asociado a los medicamentos inhibidores de la bomba de protones (IBP). Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2011:1-3. [Ref.ID 91777]
15. Cita con resumen
Gutiérrez Macías A, Ibarmia Lahuerta J, Álvarez de Castro M, Lizarralde Palacios E. Hipomagnesemia grave en relación con omeprazol. Rev Clin Esp 2011;211:488-9. [Ref.ID 91560]
16. Cita con resumen
Furlanetto TW, Faulhaber GAM. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg. Arch Intern Med 2011;171:1391-2. [Ref.ID 91365]
17. Cita con resumen
Anónimo. PPIs: too much of a good thing?. Drug Ther Bull 2011;49:49. [Ref.ID 91280]
18.Tiene citas relacionadas
Small GR, Chow BJW, So DYF. Coprescription of clopidogrel and proton pump inhibitors. JAMA 2011;342:b4351. [Ref.ID 90943]
19. Cita con resumen
Greene JA, Kesselheim AS. Why do the same drugs look different? Pills, trade dress, and public health. N Engl J Med 2011;365:83-9. [Ref.ID 90909]
20.Tiene citas relacionadas Cita con resumen
Charlot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, Lindhardsen J, Madsen JK, Kober L, Torp-Pedersen C, Gislason GH. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study . BMJ 2011;342:d2690. [Ref.ID 90752]
Seleccionar todas
 
 1 a 20 de 130 siguiente >>